• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor, pharmacist or nurse.
• This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
• If you get any side effects talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

1. What Gliclazide tablets are and what they are used for
2. What you need to know before you take Gliclazide tablets
3. How to take Gliclazide tablets
4. Possible side effects
5. How to store Gliclazide tablets
6. Contents of the pack and other information

• If you are allergic to gliclazide or any of the other ingredients of Gliclazide tablets (listed in section 6), to other medicines of the same group (sulfonylureas), to other related medicines (hypoglycaemic sulfonamides)
• If you have insulin-dependent diabetes (type 1)
• If you have ketone bodies and sugar in your urine (this may mean you have keto-acidosis), a diabetic pre-coma and coma
• If you have severe kidney or liver disease
• If you are taking miconazole (a treatment for fungal infections) (see section Other medicines and Gliclazide tablets)
• If you are breast-feeding (see section Pregnancy and breast-feeding)

Talk to your doctor, pharmacist or nurse before taking Gliclazide tablets. You should observe the treatment plan prescribed by your doctor to achieve proper blood sugar levels. This means, apart from regular tablet intake, you observe the dietary regimen, have physical exercise and, where necessary, reduce weight.

During gliclazide treatment regular monitoring of your blood (and possibly urine) sugar level and also your glycated haemoglobin (HbA1c) is necessary.

In the first few weeks of treatment the risk of having reduced blood sugar levels (hypoglycaemia) may be increased. So particularly close medical monitoring is necessary.

Low blood sugar (hypoglycaemia) may occur:

• If you take meals irregularly or skip meals altogether
• If you are fasting
• If you are malnourished
• If you change your diet
• If you increase your physical activity and carbohydrate intake does not match this increase
• If you drink alcohol, especially in combination with skipped meals
• If you take other medicines or natural remedies at the same time
• If you take too high doses of gliclazide
• If you suffer from particular hormone-induced disorders (functional disorders of the thyroid gland, of the pituitary gland or adrenal cortex)
• If your kidney function or liver function is severely decreased

If you have low blood sugar you may have the following symptoms: headache, intense hunger, nausea, vomiting, weariness, sleep disorders, restlessness, aggressiveness, poor concentration, reduced alertness and reaction time, depression, confusion, speech or visual disorders, tremor, sensory disturbances, dizziness, and helplessness.

The following signs and symptoms may also occur: sweating, clammy skin, anxiety, fast or irregular heartbeat, high blood pressure, sudden strong pain in the chest that may radiate into nearby areas (angina pectoris).

If blood sugar levels continue to drop you may suffer from considerable confusion (delirium), develop convulsions, lose self-control, your breathing may be shallow and your heartbeat slowed down, you may become unconscious. In most cases the symptoms of low blood sugar vanish very quickly when you consume some form of sugar, e.g. glucose tablets, sugar cubes, sweet juice, sweetened tea. You should therefore always carry some form of sugar with you (glucose tablets, sugar cubes).

Remember that artificial sweeteners are not effective.

Please contact your doctor or the nearest hospital if taking sugar does not help or if the symptoms recur.

Symptoms of low blood sugar may be absent, less obvious or develop very slowly or you are not aware in time that your blood sugar level has dropped. This may happen if you are an elderly patient taking certain medicines (e.g. those acting on the central nervous system and beta blockers).

If you are in stress-situations (e.g. accidents, surgical operations, fever etc.) your doctor may temporarily switch you to insulin therapy.

Symptoms of high blood sugar (hyperglycaemia) may occur when gliclazide has not yet sufficiently reduced the blood sugar, when you have not complied with the treatment plan prescribed by your doctor, if you take St John’s Wort (Hypercium perforatum) preparations (see section Other medicine and Gliclazide tablets) or in special stress situations. These may include thirst, frequent urination, dry mouth, dry itchy skin, skin infections and reduced performance.

If these symptoms occur, you must contact your doctor, pharmacist or nurse.

While taking Gliclazide tablets you should:

• Follow a regular diet: it is important to eat regular meals, including breakfast and never to miss or delay a meal
• Take your medicine regularly (see How to take Gliclazide tablets)
• Check your blood glucose regularly as recommended by your doctor

Blood glucose disturbance (low blood sugar and high blood sugar) can occur when gliclazide is prescribed at the same time as medicines belonging to a class of antibiotics called fluroquinolones, especially in elderly patients. In this case, your doctor will remind you the importance of monitoring your blood glucose.

Gliclazide tablets are not recommended for use in children.

Tell your doctor, pharmacist or nurse if you are taking, have recently taken or might take any other medicines. The blood sugar lowering effect of gliclazide may be strengthened and signs of low blood sugar levels may occur when one of the following medicines is taken:

• Other medicines used to treat high blood sugar (oral antidiabetics, GLP-1 receptor inhibitors or insulin)
• Antibiotics (e.g. sulfonamides, clarithromycin)
• Medicines to treat high blood pressure or heart failure (beta blockers, ACE-inhibitors such as captopril or enalapril)
• Medicines to treat fungal infections (miconazole, fluconazole)
• Medicines to treat ulcers in the stomach or duodenum (H2 receptor antagonists)
• Medicines to treat depression (monoamine oxidase inhibitors)
• Painkiller or antirheumatics (phenylbutazone, ibuprofen)
• Medicines containing alcohol

The blood glucose lowering effect of gliclazide may be weakened and raised blood sugar levels may occur when one of the following medicines is taken:

• Medicines to treat disorders of the central nervous system (chlorpromazine)
• Medicines reducing inflammation (corticosteroids)
• Medicines to treat asthma or used during labour (intravenous salbutamol, ritodrine and terbutaline)
• Medicines to treat breast disorders, heavy menstrual bleeding and endometriosis (danazol)
• St John’s Wort - Hypericum perforatum – preparations

Blood glucose disturbance (low blood sugar and high blood sugar) can occur when a medicine belonging to a class of antibiotics called fluroquinolones is taken at the same time as Gliclazide tablets, especially in elderly patients.

Gliclazide tablets may increase the effects of medicines which reduce blood clotting (e.g. warfarin).

Consult your doctor before you start taking another medicinal product. If you go into hospital tell the medical staff you are taking Gliclazide tablets.

Gliclazide tablets can be taken with food and non-alcoholic drinks. Drinking alcohol is not recommended as it can alter the control of your diabetes.

Gliclazide tablets are not recommended for use during pregnancy.

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby ask your doctor for advice before taking this medicine.

You must not take Gliclazide tablets while you are breast-feeding.

Provided your blood glucose levels are satisfactorily controlled on Gliclazide tablets, your ability to drive or use machines should not be affected. However, if your blood glucose levels become too low, this could adversely affect your concentration, and therefore your ability to perform these tasks.

Ask your doctor whether you can drive a car if you:

• Have frequent episodes of low blood sugar (hypoglycaemia)
• Have few or no warning signals of low blood sugar (hypoglycaemia)

If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.

The safety and efficacy of Gliclazide tablets in children and adolescents have not been established. No data is available.

Gliclazide tablets are for oral use.

Swallow your tablets whole (and preferably at the same time each day). Do not chew them.

Take your tablet(s) with a glass of water before a meal.

The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses.

If you take too many tablets, contact your doctor or the nearest hospital Accident & Emergency department immediately.

The signs of overdose are those of low blood sugar (hypoglycaemia) described in Section 2.

The symptoms can be helped by taking sugar (4 to 6 lumps) or sugary drinks straight away, followed by a substantial snack or meal. If the patient is unconscious, immediately inform a doctor and call the emergency services.

It is important to take your medicine every day as regular treatment works better. However, if you forget to take a dose of Gliclazide tablets, take the next dose at the usual time. Do not take a double dose to make up for a forgotten dose.

As the treatment for diabetes is usually life long, you should discuss with your doctor before stopping this medicinal product.

Stopping could cause high blood sugar (hyperglycaemia) which increases the risk of developing complications of diabetes.

Digestive disorders: abdominal pain, nausea, vomiting, indigestion, diarrhoea and constipation. These effects are reduced when Gliclazide tablets are taken with a meal as recommended.

Skin disorders: skin reactions such as rash, redness, itching, hives, angioedema (rapid swelling of tissues such as eyelids, face, lips, mouth, tongue or throat that may result in breathing difficulty) have been reported. The rash may progress to widespread blistering or peeling of the skin. Exceptionally, signs of severe hypersensitivity reactions (DRESS) have been reported: initially as flu-like symptoms and a rash on the face then an extended rash with a high temperature.

Blood disorders: decrease in the number of cells in the blood (e.g. platelets, red and white blood cells) which may cause paleness, prolonged bleeding, bruising, sore throat and fever. These symptoms usually stop when the treatment is discontinued.

Liver disorders: there have been isolated reports of abnormal liver function which can cause yellow skin and eyes. If you get this, see your doctor immediately. The symptoms generally disappear if the drug is stopped. Your doctor will decide whether to stop your treatment.

Eye disorders: your vision may be affected for a short time, especially at the start of treatment. This effect is due to changes in blood sugar levels.

As for other sulfonylureas, the following adverse events have been observed: cases of severe changes in the number of blood cells and allergic inflammation of the wall of blood vessels, reduction in blood sodium (hyponatraemia), symptoms of liver impairment (e.g. jaundice) which in most cases disappeared after withdrawal of the sulfonylurea, but may lead to life threatening liver failure in isolated cases.

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

The active substance is gliclazide. Each uncoated tablet contains 160 mg of gliclazide.

The other ingredients are: lactose monohydrate, microcrystalline cellulose PH 101, povidone (K-30), microcrystalline cellulose PH 102, sodium starch glycolate (Type A), talc and magnesium stearate.

Gliclazide 160 mg tablets are white to off-white, flat faced, oval shaped bevel edged, uncoated tablet, debossed “160” on one side and score line on the other side.

The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses.

Gliclazide tablets are supplied in blister packs of 14, 28 and 56 tablets. Not all pack sizes may be marketed.